Advertisement

LFVN

LifeVantage Corporation

Consumer Defensive · USD

Set alert

Price alert · LFVN

All alert types
5.88 USD +0.01 +0.17%
As of Oct 30, 2026 Extended hours 5.88 0.00%
Bid
5.77 × 1
Ask
5.88 × 1
5.78 Day range 5.90
4.02 52-week range 10.70
YTD
-4.55%
1 year
-27.14%
Open
5.87
Prev close
5.87
Mkt cap
74.03M
Vol
24.07K
Avg vol
42.22K
EPS
0.40
P/E
14.70
Div yield
0.94%
More statistics
Low
5.78
High
5.90
Forward P/E
19.70
Beta
0.86
Short ratio
2.11
Inst. own
37.13%
Dividend
0.16
Ex-div date
Dec 1, 2024
50-d avg
13.94
200-d avg
9.25
1y target
26.00

2Y chart

Chart tools
Interval
LFVN two-year price chart3.909.7715.621.527.4Oct 24Mar 25Aug 25Jan 26Jun 26Oct 26

Key statistics

Market cap
204.79M
Enterprise value
216.20M
Trailing P/E
51.09
Forward P/E
19.70
PEG ratio
0.00
Price / sales
1.04
Price / book
7.37
EPS (TTM)
0.32
Beta
0.86
Dividend yield
0.94%
Payout ratio
46.88%
Profit margin
2.11%
Revenue (TTM)
196.01M
Revenue growth
-8.10%
Free cash flow
6.92M
Total cash
14.60M
Total debt
13.36M
Return on equity
14.51%
Shares outstanding
12.53M
Short % of float
1.97%
50-day average
13.94
200-day average
9.25

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 26.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate 0.14.

Earnings history

Financials — quick view

All financials
LFVN Revenue — quarterly 42.38M
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026
LFVN Net income — quarterly 1.28M
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026
LFVN EPS — quarterly 0.10
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026

Earnings

LFVN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Oct 29, 2024Sep 1, 20240.000.15——
Aug 28, 2024Jun 1, 20240.000.14——
May 2, 2024Mar 1, 20240.000.21——
Jan 30, 2024Dec 1, 20230.000.10——
Nov 9, 2023Sep 1, 20230.000.13——
Aug 28, 2023Jun 1, 20230.000.17——

Upgrades / downgrades

LFVN analyst upgrades and downgrades
DateFirmActionFromTo
Dec 19, 2024Lake Streetinit—Buy
Feb 12, 2014Imperial Capitalinit—In-Line

About LifeVantage Corporation

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement designed to strengthen immune health; LifeVantage Rise AM & Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3, vitamin K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, hand creams, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company is headquartered in Lehi, Utah.

Sector
Consumer Defensive
Industry
Packaged Foods
Country
United States

News

Your note

Sign in to keep a note on LFVN — it syncs with the Stock Master app.

Insider holders

LFVN insider holders
InsiderRelationLatest transactionDateShares held
ANBALAGAN RAJENDRANDirectorStock Award(Grant)Nov 6, 202410,468
AURE CARLChief Financial OfficerConversion of Exercise of derivative securitySep 30, 2024138,746
BEINDORFF MICHAEL ADirectorStock Award(Grant)Nov 6, 2024130,072
CUNNINGHAM KRISTENOfficerConversion of Exercise of derivative securitySep 30, 2024107,581
GREER RAYMOND BDirectorStock Award(Grant)Nov 6, 2024107,288
JUDD DAYTON RDirectorStock Award(Grant)Nov 6, 2024782,956

Institution ownership

LFVN institution ownership
Holder% heldSharesValueReported
Renaissance Technologies, LLC6.61%828,11813.54MSep 29, 2024
Vanguard Group Inc3.97%497,7788.14MSep 29, 2024
Capital Management Corporation3.35%419,9306.87MSep 29, 2024
Dimensional Fund Advisors LP2.37%296,3714.85MSep 29, 2024
Envestnet Asset Management1.78%222,8733.64MSep 29, 2024
Blackrock Inc.1.60%200,1563.27MSep 29, 2024

Fund ownership

LFVN fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.31%289,6134.74MSep 29, 2024
Vanguard Extended Market Index Fund1.56%195,1133.19MSep 29, 2024
EA Series Trust-EA Bridgeway Omni Small-Cap Value ETF0.63%78,8591.29MSep 29, 2024
DFA U.S. Small Cap Series0.58%72,7271.19MJul 30, 2024
Avantis U.S. Small Cap Value ETF0.50%62,0761.01MSep 29, 2024
Fidelity Extended Market Index Fund0.48%59,513973.04KOct 30, 2024
Advertisement